Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma

BACKGROUND: Recurrence is common in glioblastoma multiforme (GBM) because of the infiltrative, residual cells in the tumor margin. Standard therapy for GBM consists of surgical resection followed by chemotherapy and radiotherapy, but the median survival of GBM patients remains poor (~ 1.5 years). Fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Hanwool, Byun, Joonho, Kang, Hayeong, Kim, Kyunggon, Lee, Eunyeup, Kim, Jeong Hoon, Hong, Chang Ki, Song, Sang Woo, Kim, Young-Hoon, Chong, Sangjoon, Kim, Jae Hyun, Nam, Soo Jeong, Park, Ji Eun, Lee, Seungjoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893563/
https://www.ncbi.nlm.nih.gov/pubmed/36732815
http://dx.doi.org/10.1186/s12967-023-03936-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893563/
https://www.ncbi.nlm.nih.gov/pubmed/36732815
http://dx.doi.org/10.1186/s12967-023-03936-8

Ejemplares similares